Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Sponsor: Coherus Oncology, Inc.
Summary
The main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for casdozokitug in combination with toripalimab plus bevacizumab.
Official title: A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2024-12-20
Completion Date
2027-09
Last Updated
2026-02-05
Healthy Volunteers
No
Conditions
Interventions
Casdozokitug
Solution for infusion
Toripalimab
Solution for infusion
Bevacizumab
Solution for infusion
Locations (44)
Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
University of Arizona - Cancer Center
Tucson, Arizona, United States
Beverly Hills Cancer Center
Beverly Hills, California, United States
City of Hope
Duarte, California, United States
City of Hope at Irvine Lennar
Irvine, California, United States
Cancer & Blood Specialty Clinic
Lakewood, California, United States
USC Norris Comprehensive Cancer Center
Los Angeles, California, United States
Sarcoma Oncology Center
Santa Monica, California, United States
Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
The Winship Cancer Institute Emory University
Atlanta, Georgia, United States
Mountain States Tumor Institute at St. Luke's Regional Medical Center
Boise, Idaho, United States
University of Kansas Cancer Center
Kansas City, Kansas, United States
UofL Health Brown Cancer Center
Louisville, Kentucky, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
Christus St. Vincent Regional Medical Center
Santa Fe, New Mexico, United States
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
University of North Carolina (UNC) - Chapel Hill
Chapel Hill, North Carolina, United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James)
Columbus, Ohio, United States
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Prisma Health Cancer Institute
Greenville, South Carolina, United States
Virginia Cancer Specialists
Fairfax, Virginia, United States
Virginia Oncology Associates
Norfolk, Virginia, United States
UW Carbone Cancer Center - Cancer Connect
Madison, Wisconsin, United States
Royal Brisbane and Women's Hospital
Herston, Brisbane, Australia
Bankstown-Lidcombe Hospital
Bankstown, New South Wales, Australia
Monash Health
Melbourne, Victoria, Australia
St Vincent's Hospital Sydney
Darlinghurst, Australia
Linear Clinical Research
Nedlands, Australia
Sunnybrook Health Sciences Centre - Bayview Campus
Toronto, Ontario, Canada
Princess Margaret Hospital
Toronto, Ontario, Canada
Prince of Wales Hospital
Shatin, New Territories, Hong Kong
Queen Mary Hospital
Hong Kong, Pok Fu Lam, Hong Kong
Humanity & Health Clinical Trial Centre
Hong Kong, Hong Kong
National Cancer Centre Singapore
Singapore, Singapore
Tan Tock Seng Hospital
Singapore, Singapore
Curie Oncology
Singapore, Singapore
China Medical University Hospital
Taichung, Taichung City, Taiwan
National Cheng Kung University Hospital
Tainan, Tainan City, Taiwan
National Taiwan University Hospital
Tainan, Taipei City, Taiwan
Taipei Veterans General Hospital
Taipei, Taipei City, Taiwan
Chi Mei Medical Center
Tainan, Taiwan
Linkou Chang Gung Memorial Hospital (CGMHLK)
Taoyuan, Taiwan